Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Timothy S. Oh"'
Autor:
Narendranath Epperla, Rina Li Welkie, Pallawi Torka, Geoffrey Shouse, Reem Karmali, Lauren Shea, Andrea Anampa-Guzmán, Timothy S. Oh, Heather Reaves, Montreh Tavakkoli, Kathryn Lindsey, Irl Brian Greenwell, Emily Hansinger, Colin Thomas, Sayan Mullick Chowdhury, Kaitlin Annunzio, Beth Christian, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Nancy L. Bartlett, Alex F. Herrera, Natalie S. Grover, Adam J. Olszewski
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-6 (2023)
Abstract Progression of disease within 24 months (POD24) from diagnosis in marginal zone lymphoma (MZL) was shown to portend poor outcomes in prior studies. However, many patients with MZL do not require immediate therapy, and the time from diagnosis
Externí odkaz:
https://doaj.org/article/4835afa60d3d4971aa7119bfb3356cb7
Autor:
Alexandra Rezazadeh, Aniko Szabo, Arushi Khurana, David J. Inwards, Matthew A. Lunning, Nancy L. Bartlett, Paolo F. Caimi, Thomas D. Rodgers, Paul M. Barr, Sayan Mullick Chowdhury, Narendranath Epperla, Hiruni Mendries, Brian T. Hill, Timothy S. Oh, Reem Karmali, Julie E. Chang, Gaurav Goyal, Benjamin M. Parsons, Krista M. Isaac, Craig A. Portell, Kathleen Monahan, Malika Siker, David M. King, Timothy S. Fenske
Publikováno v:
Haematologica, Vol 109, Iss 5 (2023)
Primary bone diffuse large B-cell lymphoma is a rare variant of extranodal non-Hodgkin lymphoma historically treated with induction chemotherapy followed by consolidative radiation therapy (RT). It remains unknown whether RT confers additional benefi
Externí odkaz:
https://doaj.org/article/0727d9f9e19e46789eea66cdd1b56826
Publikováno v:
Case Reports in Hematology, Vol 2022 (2022)
Mantle cell lymphoma (MCL) is an aggressive, difficult to treat subtype of lymphoma, resulting in relapses and poor outcomes. Novel agents such as Bruton tyrosine kinase (BTK) inhibitors have been studied in the treatment of relapsed/refractory (R/R)
Externí odkaz:
https://doaj.org/article/6ee13fbbe6674fbd952bc7f410ec2ccc
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 23, p 14543 (2022)
Despite many recent advances in treatment options, acute myeloid leukemia (AML) still has a high mortality rate. One important issue in optimizing outcomes for AML patients lies in the limited ability to predict response to specific therapies, durati
Externí odkaz:
https://doaj.org/article/0172668aad74457798722e58f5e1f3d6
Autor:
Danielle N. Horridge, Timothy S. Oh, Jorge Alonzo, Lilli Mann-Jackson, Amanda E. Tanner, Eunyoung Y. Song, Benjamin D. Smart, Cornelius N. Van Dam, Logan S. Baker, Scott D. Rhodes
Publikováno v:
Health Behavior Research, Vol 2, Iss 3 (2019)
Gay, bisexual, and other men who have sex with men (GBMSM) have higher rates of HIV infection compared to the general population in the United States, and the infection rate is growing among Latinx GBMSM, compared to a decline in most other demograph
Externí odkaz:
https://doaj.org/article/f7a6df592c72461b9d7d9a5e0661fe58
Autor:
Adam Stephen Zayac, Daniel J. Landsburg, Mitchell E. Hughes, Allison M. Bock, Grzegorz S. Nowakowski, Emily C. Ayers, Mark Ryan Girton, Marie Hu, Amy K. Beckman, Shaoying Li, L. Jeffrey Medeiros, Julie E Chang, Adam Stepanovic, Habibe Kurt, Jose Sandoval-Sus, Mohammad Ali Ansari-Lari, Shalin K. Kothari, Anna Kress, Mina L Xu, Pallawi Torka, Suchitra Sundaram, Stephen D Smith, Kikkeri N Naresh, Yasmin H. Karimi, Narendranath Epperla, David A Bond, Umar Farooq, Mahak Saad, Andrew M Evens, Karan Pandya, Seema G. Naik, Manali Kamdar, Bradley M Haverkos, Reem Karmali, Timothy S Oh, Julie M Vose, Heather R Nutsch, Paul G. Rubinstein, Amina Chaudhry, Adam J Olszewski
Publikováno v:
Blood Advances.
In this multi-institutional retrospective study, we examined characteristics and outcomes of 160 patients with high-grade B-cell lymphoma, not otherwise specified (HGBL-NOS). This rare lymphoma category is defined by high-grade morphologic features,
Autor:
Narendranath Epperla, Adam Zayac, Daniel J. Landsburg, Mitchell Hughes, Allison M. Bock, Grzegorz S. Nowakowski, Emily C. Ayers, Mark Girton, Marie Hu, Amy Beckman, Shaoying Li, L. Jeffrey Medeiros, Julie E. Chang, Adam Stepanovic, Habibe Kurt, Jose Sandoval-Sus, M. Ali Ansari-Lari, Shalin K. Kothari, Anna Kress, Mina L Xu, Pallawi Torka, Suchitra Sundaram, Stephen D Smith, Kikkeri N Naresh, Yasmin Karimi, David A. Bond, Umar Farooq, Mahak Saad, Andrew Matthew Evens, Karan Pandya, Seema G Naik, Manali Kamdar, Bradley M. Haverkos, Reem Karmali, Timothy S Oh, Julie M. Vose, Heather Nutsch, Paul Rubinstein, Amina Chaudhry, Adam J. Olszewski
Publikováno v:
Blood. 140:3839-3841
Publikováno v:
Kompass Onkologie. 9:141-145
Das Mantelzelllymphom (MCL) ist eine aggressive, schwer zu behandelnde Unterform des Lymphoms, die zu Rückfällen und schlechten Behandlungsergebnissen führt. Neuartige Wirkstoffe wie Bruton-Tyrosinkinase (BTK)-Inhibitoren wurden für die Behandlun
Autor:
Erin L. Sutfin, Nicole F Rojas, Eun-Young Song, Caryn G. Morse, Scott D. Rhodes, Aimee M. Wilkin, Kristie L. Foley, Timothy S. Oh, David Choi, Lilli Mann-Jackson
Publikováno v:
J Cancer Educ
Persons living with HIV (PLWH) have disproportionately high rates of both cigarette smoking and tobacco-induced negative health outcomes. The goal of this qualitative systematic review was to identify gaps in the existing literature and future direct
Autor:
M. Ali Ansari-Lari, Brad M. Haverkos, Anna Kress, Andrew M. Evens, Yasmin Karimi, Adam J. Olszewski, Julie M. Vose, Adam Zayac, L. Jeffrey Medeiros, David A. Bond, Paul Rubinstein, Emily C. Ayers, Manali Kamdar, Amina Chaudhry, Mitchell E. Hughes, Karan Pandya, Shalin Kothari, Amy Beckman, Suchitra Sundaram, Mina L. Xu, Stephen D. Smith, Marie Hu, Daniel J. Landsburg, Mark Girton, Habibe Kurt, Reem Karmali, Timothy S. Oh, Heather Nutsch, Jose Sandoval-Sus, Seema Naik, Pallawi Torka, Shaoying Li, Narendranath Epperla, Kikkeri N Naresh
Publikováno v:
Blood. 138:455-455
Background: The term HGBL, NOS was introduced by the World Health Organization (WHO) in 2016 for aggressive B-cell lymphomas with Burkitt lymphoma-like (BLL) or blastoid cytomorphology that lack double-hit genetics and do not meet criteria for other